Products for assisted reproduction

Vitrolife

Vitrolife is a Swedish medtech company focused on developing, manufacturing and marketing products used in In Vitro Fertilsation (IVF). Vitrolife offers its customers a wide range of products and solutions, including culture media, disposable products and capital equipment products. Vitrolife is a global company, with sales in some 110 countries.

Financials

Vitrolife

SEKm 2018 2019 2020
Sales 1151 1368 1478
Sales growth (%) 10 18,8 8
EBITDA 479 542 585
EBITDA margin (%) 41,6 39,6 39,6
EBIT adj 411 460 502
EBIT adj margin (%) 35,7 33,6 34
Pretax profit 399 462 504
EPS rep 2,86 3,3 3,6
EPS growth (%) 17,4 15,2 9,2
EPS adj 3,32 3,69 3,99
DPS 0,85 1 1
EV/EBITDA (x) 32,3 36 32,8
EV/EBIT adj (x) 37,6 42,4 38,2
P/E (x) 51,4 56,7 51,9
P/E adj (x) 44,2 50,7 46,8
EV/sales (x) 13,4 14,2 13
FCF yield (%) 1,1 2 2,1
Dividend yield (%) 0,6 0,5 0,5
Net IB debt/EBITDA -1 -1,5 -1,9

Main shareholders

Vitrolife

Main shareholders Share capital % Voting shares % Verified
William Demant Invest A/S 22.6 % 22.6 % 31 Jan 2019
Bure Equity 20.8 % 20.8 % 31 Jan 2019
Capital Group 4.6 % 4.6 % 31 Dec 2018
Lannebo Fonder 3.2 % 3.2 % 31 Dec 2018
Morgan Stanley Investment Management 2.8 % 2.8 % 31 Dec 2018
Norges Bank 2.1 % 2.1 % 31 Jan 2019
Eccenovo AB 2.1 % 2.1 % 31 Jan 2019
Vanguard 1.6 % 1.6 % 31 Jan 2019
GLG Partners 1.2 % 1.2 % 31 Dec 2018
SEB Fonder 1.0 % 1.0 % 31 Jan 2019
Source: Holdings by Modular Finance AB

Insider list

Vitrolife

Name
Mikael Engblom
Barbro Fridén
Thomas Axelsson
Mikael Engblom
Mikael Engblom
Mikael Engblom
Mikael Engblom
Helena Engblom
Mikael Engblom
Thomas Axelsson
Show More